Top Stories: KMG Chemicals Inc. (NYSE:KMG), Recro Pharma (NASDAQ:REPH), Boston Scientific Corporation (NYSE:BSX), Kraft Foods Group (NASDAQ:KRFT), Oxford Immunotec Global (NASDAQ:OXFD)


On Tuesday shares of KMG Chemicals Inc. (NYSE:KMG) closed at $24.63. Company’s sales growth for last 5 years was 13.10% and EPS growth for next 5 years is recorded as 17.00%. On March 12, KMG Chemicals, Inc. (NYSE: KMG), a global provider of specialty chemicals to select markets, announced financial results for the fiscal 2015 second quarter ended January 31, 2015. Consolidated net sales were $79.8 million, a 5% decrease from last year’s second quarter. Sales declined due to reduced creosote volume and the divestiture of the creosote business in January. Adjusted EBITDA increased to $9.0 million, up 50% from $6.0 million in last year’s second quarter.

Recro Pharma, Inc. (NASDAQ:REPH) in last trading activity increased 11.10% to close at $8.31. Company weekly performance is 51.92% while its quarterly performance stands at 224.61%. Recro Pharma, Inc. (NASDAQ:REPH) is -15.89% away from its 52 week high. On March 9, Recro Pharma, Inc. (NASDAQ:REPH) announced a definitive agreement under which Recro Pharma will acquire assets from Alkermes plc including worldwide rights to IV/IM meloxicam, a proprietary, Phase III-ready, long-acting COX-2 NSAID for moderate to severe acute pain, as well as a contract manufacturing facility, royalty and formulation business in Gainesville, GA.

On Tuesday shares of Boston Scientific Corporation (NYSE:BSX) closed at $17.40. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 9.87%. Boston Scientific Corp (NYSE:BSX) on Tuesday said it has received FDA and CE Mark approval of the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) System. The EMBLEM S-ICD System is a treatment option that provides protection for patients at risk of sudden cardiac arrest, yet leaves the heart and vasculature untouched, minimizing the risk of complications associated with conventional transvenous implantable cardioverter-defibrillators.

Kraft Foods Group, Inc. (NASDAQ:KRFT) in last trading activity moved down -0.56% to close at $61.70. Company weekly performance is 0.50% while its quarterly performance stands at 6.00%. Kraft Foods Group, Inc. (NASDAQ:KRFT) is -8.92% away from its 52 week high. Kraft Foods Group, Inc. (NASDAQ:KRFT) is recalling more than 6.5 million boxes of its signature macaroni and cheese after customers reported finding small pieces of metal inside.

On last trading day Oxford Immunotec Global PLC (NASDAQ:OXFD) increased 0.14% to close at $14.63. Its volatility for the week is 3.67% while volatility for the month is 5.40%. OXFD’s sales growth for past 5 years was 63.00% and its EPS growth for past 5 years was -9.90%. Oxford Immunotec Global PLC (NASDAQ:OXFD) monthly performance is 15.56%. Oxford Immunotec Global PLC (NASDAQ:OXFD), announced that Stephen M. Gansler has joined the Company as Senior Vice President and Global Head of Human Resources. Mr. Gansler brings to Oxford Immunotec more than 25 years of experience in managing and leading the human resource function at life sciences companies.


Leave a Reply

Your email address will not be published. Required fields are marked *